A retrospective analysis assessing the clinical efficacy and SLAMF7 patterns after treatment with Elotuzumab for the treatment of extramedullary myeloma
Latest Information Update: 09 Jun 2021
At a glance
- Drugs Elotuzumab (Primary) ; Daratumumab; Dexamethasone; Lenalidomide; Pomalidomide; Thalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 09 Jun 2021 New trial record
- 01 Jun 2021 Results published in the Annals of Hematology